Chylobinoid(Synthonics)

N/A

Report date: 2024/08/27 20:00:19
NME

Base Information

Drug NameChylobinoid(Synthonics)
Drug Alias NameCannabidiolic Acid(Synthonics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRestless Legs Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSynthonics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSynthonics Inc
Inactive CompaniesN/A
Active IndicationsRestless Legs Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A